Related Experiment Videos
Will the current measles vaccines ever eradicate measles?
1Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK. john.stephenson@lshtm.ac.uk
Expert Review of Vaccines
|August 7, 2003
Summary
Measles vaccines have dramatically reduced disease, but limitations like maternal antibodies and heat sensitivity persist. Concerns about side effects are impacting uptake, driving research into alternative vaccine technologies.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Measles virus is highly contagious, causing severe complications and historically high child mortality.
- Live attenuated measles vaccines have significantly reduced disease incidence globally.
- High vaccine uptake has led to the near elimination of indigenous measles in many regions.
Purpose of the Study:
- To review the efficacy and limitations of current measles vaccines.
- To discuss challenges including maternal antibodies, heat lability, and public concerns.
- To explore the need for novel vaccine approaches in response to these limitations.
Main Methods:
- Literature review of measles epidemiology and vaccine development.
- Analysis of vaccine efficacy, safety profiles, and public perception.
- Examination of factors affecting vaccine uptake and challenges in diverse settings.
Main Results:
- Current measles vaccines are highly effective but face challenges with infant immunization and heat stability.
- Public concerns regarding vaccine safety, though unsubstantiated, impact vaccination rates.
- Severe vaccine complications are rare, but mild reactions are more common.
Conclusions:
- Despite high efficacy, limitations of current measles vaccines necessitate ongoing research.
- Addressing public concerns and improving vaccine accessibility are crucial for sustained measles control.
- Development of non-replicating measles vaccines may offer future solutions, particularly in low-resource settings.